{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:00:04Z","timestamp":1791658804529,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003965","name":"Migraine Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003983","name":"National Headache Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Migraine Foundation"},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biohaven"},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.mayocp.2019.11.025","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T08:07:09Z","timestamp":1585728429000},"page":"709-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Characterization of Acute Prescription Migraine Medication Use"],"prefix":"10.1016","volume":"95","author":[{"given":"Susan","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey Manack","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2019.11.025_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine\u2013current understanding and treatment","volume":"346","author":"Goadsby","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.025_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.025_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102410381145","article-title":"Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)","volume":"31","author":"Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.mayocp.2019.11.025_bib4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","article-title":"Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.025_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0333102412468668","article-title":"Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan","volume":"33","author":"Wang","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.025_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11916-013-0385-0","article-title":"Economic burden and costs of chronic migraine","volume":"18","author":"Lanteri-Minet","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"12","key":"10.1016\/j.mayocp.2019.11.025_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/JOM.0000000000001450","article-title":"Direct and indirect costs among United States commercially insured employees with migraine","volume":"60","author":"Gilligan","year":"2018","journal-title":"J\u00a0Occup Environ Med"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.025_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.mayocp.2016.02.013","article-title":"Impact of migraine on the family: perspectives of people with migraine and their spouse\/domestic partner in the CaMEO Study","volume":"91","author":"Buse","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"36","key":"10.1016\/j.mayocp.2019.11.025_bib9","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.3748\/wjg.v22.i36.8149","article-title":"Gastrointestinal disorders associated with migraine: a comprehensive review","volume":"22","author":"Camara-Lemarroy","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","article-title":"Migraine and its psychiatric comorbidities","volume":"87","author":"Minen","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.mayocp.2019.11.025_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mayocp.2019.11.025_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","article-title":"Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life","volume":"84","author":"Buse","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2019.11.025_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s40064-016-2211-8","article-title":"Recent advances in migraine therapy","volume":"5","author":"Antonaci","year":"2016","journal-title":"SpringerPlus"},{"issue":"8","key":"10.1016\/j.mayocp.2019.11.025_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1468-2982.2008.01819.x","article-title":"The acute treatment of episodic and chronic migraine in the USA","volume":"29","author":"Bigal","year":"2009","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.025_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1526-4610.2003.03027.x","article-title":"Single use of sumatriptan: a patient interview study","volume":"43","author":"Rahimtoola","year":"2003","journal-title":"Headache"},{"issue":"suppl 3","key":"10.1016\/j.mayocp.2019.11.025_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1185\/030079905X46269","article-title":"Part I: what do patients really need and want from migraine treatment?","volume":"21","author":"Gendolla","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.025_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1526-4610.2007.00752.x","article-title":"Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden","volume":"47","author":"Bigal","year":"2007","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.025_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0333102410383058","article-title":"Triptan persistency among newly initiated users in a pharmacy claims database","volume":"31","author":"Katic","year":"2011","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.025_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02265.x","article-title":"Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features","volume":"53","author":"Lipton","year":"2013","journal-title":"Headache"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.11.025_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2012.12.020","article-title":"Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study","volume":"326","author":"Holland","year":"2013","journal-title":"J\u00a0Neurol Sci"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/head.12404","article-title":"Treatment persistence and switching in triptan users: a systematic literature review","volume":"54","author":"Messali","year":"2014","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.025_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/head.12198","article-title":"Identifying the factors underlying discontinuation of triptans","volume":"54","author":"Wells","year":"2014","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine","volume":"84","author":"Lipton","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2019.11.025_bib24","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/head.12154","article-title":"Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study","volume":"53","author":"Lipton","year":"2013","journal-title":"Headache"},{"issue":"suppl 3","key":"10.1016\/j.mayocp.2019.11.025_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/head.13417","article-title":"Anti-calcitonin gene-related peptide (CGRP) therapies: update on a previous review after the American Headache Society 60th Scientific Meeting, San Francisco, June 2018","volume":"58","author":"Tepper","year":"2018","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0333102414552532","article-title":"The impact of chronic migraine: the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results","volume":"35","author":"Adams","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.mayocp.2019.11.025_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","article-title":"Cutaneous allodynia in the migraine population","volume":"63","author":"Lipton","year":"2008","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.11.025_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/EDE.0b013e31823b6296","article-title":"Berkson's bias, selection bias, and missing data","volume":"23","author":"Westreich","year":"2012","journal-title":"Epidemiology"},{"issue":"15 suppl","key":"10.1016\/j.mayocp.2019.11.025_bib29","article-title":"Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study demonstrate a high level of unmet need for migraine treatment in people who discontinue acute prescription migraine medication [abstract]","volume":"92","author":"Manack Adams","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1526-4610.2004.04124.x","article-title":"Patterns of use of triptans and reasons for switching them in a tertiary care migraine population","volume":"44","author":"Sheftell","year":"2004","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mayocp.2019.11.025_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1526-4610.2009.01343.x","article-title":"Predictors of adherence to triptans: factors of sustained vs lapsed users","volume":"49","author":"Cady","year":"2009","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.mayocp.2019.11.025_bib32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/head.12055","article-title":"Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II)","volume":"53","author":"Blumenfeld","year":"2013","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mayocp.2019.11.025_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","article-title":"Migraine diagnosis and treatment: results from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619310778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619310778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:56Z","timestamp":1758418316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619310778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0025619619310778"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.025","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Acute Prescription Migraine Medication Use","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}